Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (2)
P 2 (1)
P 3 (2)
P 4 (2)

Trial Status

Completed5
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (7)

Research Network

Activity Timeline